Please check your internet connection and try again.
# Lorazepam (representative Benzodiazepine)
## Overview
Lorazepam is a short-acting benzodiazepine with anxiolytic, sedative, hypnotic, and anticonvulsant properties. It acts by enhancing the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABAA receptor.
## Primary Indications
* **Anxiety Disorders:** Management of anxiety symptoms.
* **Insomnia:** Short-term treatment of sleep difficulties.
* **Status Epilepticus:** First-line treatment for terminating seizures.
* **Preoperative Sedation:** To reduce anxiety and provide amnesia prior to surgical procedures.
* **Alcohol Withdrawal Syndrome:** Management of symptoms.
## Adult Dosing
Dosing varies significantly based on indication and patient response. Titration is often necessary.
* **Anxiety:** Typically 1-4 mg given orally in 2-3 divided doses daily. Maximum daily dose usually not to exceed 10 mg.
* **Insomnia:** 2-4 mg given orally at bedtime.
* **Status Epilepticus:** 4 mg given intravenously (IV) or intramuscularly (IM). Repeat doses may be given after 10-15 minutes if seizures persist, up to a maximum of 8 mg in a 12-hour period. Local protocol often dictates repeat dosing intervals and total maximum.
* **Preoperative Sedation:** 2-4 mg IM given 2 hours before surgery, or 1-2 mg IV given 15-20 minutes before surgery.
## Pediatric Dosing
Dosing is highly variable and should be guided by weight, age, and clinical condition. Specific pediatric protocols are essential.
* **Status Epilepticus:** 0.1 mg/kg IV/IM, not to exceed 4 mg per dose. May repeat once after 5-10 minutes.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution; reduced doses may be necessary.
* **Renal Impairment:** Use with caution; reduced doses may be necessary.
* **Elderly:** Initiate at lower doses (e.g., half of the adult starting dose) and titrate slowly due to increased sensitivity and slower metabolism.
## Contraindications
* Known hypersensitivity to lorazepam, other benzodiazepines, or any component of the formulation.
* Acute narrow-angle glaucoma.
* Severe respiratory insufficiency.
* Severe hepatic insufficiency.
* Myasthenia gravis.
* Alcohol intoxication or coma.
## Adverse Effects
Common: Drowsiness, dizziness, weakness, unsteadiness, confusion.
Less Common: Paradoxical reactions (agitation, aggression), amnesia, hypotension, respiratory depression (especially with IV administration or in combination with other CNS depressants), dependence, withdrawal symptoms upon abrupt discontinuation.
## Key Drug Interactions
* **CNS Depressants (e.g., opioids, alcohol, antihistamines, other sedatives/hypnotics):** Additive CNS depression, increasing risk of sedation, respiratory depression, and death. Co-administration requires careful consideration and may necessitate dose reduction of one or both agents.
* **Theophylline/Aminophylline:** May decrease the sedative effects of lorazepam.
* **Valproic acid:** May increase lorazepam plasma concentrations and prolong its half-life.
## Monitoring
* Level of consciousness, sedation, and respiratory rate, especially after IV administration or in combination with other CNS depressants.
* Signs of dependence and withdrawal if used chronically.
* Efficacy for the treated condition.
## Clinical Pearls
* Lorazepam's short half-life means it is less likely to accumulate than longer-acting benzodiazepines, making it suitable for short-term use.
* IV lorazepam can cause thrombophlebitis; administer slowly and consider dilution.
* Abrupt discontinuation after prolonged use can lead to withdrawal symptoms (anxiety, insomnia, tremors, seizures). Tapering is recommended.
* Use in pregnancy should be avoided unless benefits outweigh risks, particularly in the first trimester and near term.
***
*Disclaimer: This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant guidelines for definitive guidance, as drug information can change.*
